If you're looking for MS care in New York, you can choose from 25 treatment centers across the state, including major programs in New York City and Rochester. Consider factors like specialty programs, research focus, and location when comparing centers such as Columbia University Multiple Sclerosis Center, the Corinne Goldsmith Dickinson Center for MS at Mount Sinai, and the Jacobs MS Center for Treatment and Research to find the right fit for your care.
25 MS treatment centers35 active clinical trialsTop academic centers in NYC and Rochester7 providers with Medicare prescribing data
Center types in New York
Dedicated MS Practice (9)
Academic MS Center (9)
Regional Neurology Group (4)
Boutique MS Practice (2)
Community Hospital Program (1)
Filter by type:
Centers with Most Active Trials in New York
Ranked by active clinical trial count from ClinicalTrials.gov. Not a quality ranking.
Largest Care Teams in New York
MS Care by City
Active MS clinical trials in New York
See all 43 MS trials in New York →ActivePhase 3
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)
Hoffmann-La Roche
Great Neck · New York
ActivePhase 3
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
Patchogue · Port Jefferson
ActivePhase 4
A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation
Novartis Pharmaceuticals
Syracuse
ActivePhase 3
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
Hoffmann-La Roche
Amherst · New York · +3
ActivePhase 3
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
Novartis Pharmaceuticals
Patchogue · Port Jefferson
ActivePhase 3
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Novartis Pharmaceuticals
Latham
ActivePhase 3
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
Lake Success · New York
ActivePhase 3
An Extension Study of Ublituximab in Participants With Relapsing Multiple Sclerosis
TG Therapeutics, Inc.
Amherst





















